When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Última revisão: 23 Jan 2025
Última atualização: 28 Jul 2021

Resumo

Definição

História e exame físico

Outros fatores diagnósticos

  • pouca idade
  • perda de peso
  • visão turva
  • náuseas e vômitos
  • dor abdominal
  • desidratação clínica
  • dor abdominal
  • taquipneia
  • letargia
  • coma ou estado mental alterado

Fatores de risco

  • predisposição genética
  • região geográfica
  • agentes infecciosos
  • fatores alimentares

Investigações diagnósticas

Primeiras investigações a serem solicitadas

  • glicemia plasmática aleatória (crianças)
  • glicemia de jejum (crianças)
  • glicose plasmática em 2 horas (crianças)
  • HbA1c (crianças)
  • diagnóstico clínico (adultos)

Investigações a serem consideradas

  • dosagem de corpos cetônicos séricos ou urinários
  • peptídeo C
  • marcadores autoimunes

Algoritmo de tratamento

Colaboradores

Autores

Eveleigh Nicholson, MBBS, FRCP

Consultant Endocrinologist

Portsmouth Hospitals University NHS Trust

UK

Declarações

EN has received honoraria for educational activities/advisory boards from NovoNordisk, Eli Lilly and Boehringer Ingelheim.

Sze May Ng, MBBS (Hons), FHEA, FRCPCH, SFFMLM, MSc, LLM, MBA, PhD

Honorary Associate Professor

University of Liverpool

Consultant Paediatrician and Paediatric Endocrinologist

Southport and Ormskirk NHS Trust

UK

Declarações

SMN declares that she has no competing interests.

Partha Kar, OBE, MBBS MD, FRCP

Consultant Endocrinologist

Portsmouth Hospitals University NHS Trust

National Specialty Advisor, Diabetes, NHS England

UK

Declarações

PK has sat on advisory boards and attended events reimbursed by Novo Nordisk, Eli Lilly and Sanofi.

Agradecimentos

Dr Eveleigh Nicholson, Dr Sze May Ng, and Professor Partha Kar would like to gratefully acknowledge Dr Rajesh K. Garg and Dr Varsha Vimalananda, the previous contributors to this topic.

Declarações

RKG is an author of a number of references cited in this topic. VV declares that she has no competing interests.

Revisores

Omar Mustafa, MBChB, FRCP

Consultant Physician in Diabetes

Senior Lecturer in Medical Education

King's College Hospital NHS Foundation Trust

King’s College London

London

UK

Declarações

OM has received honoraria for educational activities/lectures from NovoNordisk, Eli Lilly, Sanofi, and Boehringer Ingelheim.

Hood Thabit, MB, BCh, MD, PhD

Consultant Diabetologist & Honorary Senior Lecturer

Manchester University Hospitals NHS Foundation Trust

University of Manchester

Manchester

UK

Declarações

HT has received research support from Dexcom, Inc., and speaker fees from Eli Lilly.

O uso deste conteúdo está sujeito ao nosso aviso legal